<?xml version="1.0" encoding="UTF-8"?>
<PAPER>

<BODY>
<DIV><P>
</P>
<P>[0001] INHIBITION OF POLYMERISATION Field of the Invention
This invention relates to the inhibition of premature polymerisation of monomers, in particular ethylenically unsaturated monomers.
Background to the Invention
Many of the industrially important ethylenically unsaturated monomers are highly susceptible to unwanted radical polymerisation. Examples of these monomers include <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.42" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.70" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]-methylstyrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.253" epochem-id="EPOCHEM:NEW:COMPOUND:802" name="styrene sulphonic acid" comment="" chebi-id="WO2007045886:5313" relevant="false">styrene sulphonic acid</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.89" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, <ne id="WO2007045886.HC.class-names.157" epochem-id="EPOCHEM:NEW:CLASS:497" name="divinylbenzenes" comment="" chebi-id="WO2007045886:410477" relevant="false" type="CLASS">divinylbenzenes</ne> and <ne id="WO2007045886.HC.class-names.161" epochem-id="EPOCHEM:NEW:CLASS:498" name="dienes" comment="" chebi-id="WO2007045886:119665" relevant="false" type="CLASS">dienes</ne> such as <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.156" epochem-id="EPOCHEM:NEW:COMPOUND:810" name="butadiene" comment="" chebi-id="CHEBI:39479" relevant="false">butadiene</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.162" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>. Premature polymerisation may occur during manufacture, purification or storage of the monomer. Many of these monomers are purified by distillation. It is in this operation where premature polymerisation is most likely to occur and is the most troublesome. Methods to prevent or reduce the amount of such polymerisations are essential to prevent a dangerous runaway reaction, which can decrease cost-effectiveness of the process and be potentially explosive in nature.
Stable <ne id="WO2007045886.HC.class-names.71" epochem-id="EPOCHEM:NEW:CLASS:180" name="nitroxides" comment="" chebi-id="CHEBI:39477" relevant="false" type="CLASS">nitroxides</ne> are known to inhibit the premature polymerization of ethylenically unsaturated monomers. Many of these <ne id="WO2007045886.HC.class-names.72" epochem-id="EPOCHEM:NEW:CLASS:180" name="nitroxides" comment="" chebi-id="CHEBI:39477" relevant="false" type="CLASS">nitroxides</ne> are based on <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.254" epochem-id="EPOCHEM:NEW:COMPOUND:813" name="2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:478749" relevant="false">2,2,6,6- tetramethylpiperidine-1 -oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.285" epochem-id="EPOCHEM:COMPOUND:1618" name="TEMPO" comment="" chebi-id="CHEBI:32849" relevant="false">TEMPO</ne>"), a particular example being <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.29" epochem-id="EPOCHEM:NEW:COMPOUND:797" name="4-hydroxy- 2,2,6,6-tetramethylpiperidine-1-oxide" comment="" chebi-id="WO2007045886:624799" relevant="true">4-hydroxy-2, 2,6,6- tetramethylpiperidine-1 -oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.111" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="false">4-hydroxy-TEMPO</ne>"), i.e.
</P>
<P>[0006]
EMI2.1
US 5932735 and US 6080864 describe various <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.287" epochem-id="EPOCHEM:COMPOUND:1618" name="TEMPO" comment="" chebi-id="CHEBI:32849" relevant="false">TEMPO</ne> derivatives which are stated to be useful in inhibiting the premature polymerisation of unsaturated <ne id="WO2007045886.HC.class-names.169" epochem-id="EPOCHEM:NEW:CLASS:500" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne>, <ne id="WO2007045886.HC.class-names.74" epochem-id="EPOCHEM:NEW:CLASS:44" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne>, <ne id="WO2007045886.HC.class-names.78" epochem-id="EPOCHEM:NEW:CLASS:181" name="amides" comment="" chebi-id="CHEBI:32988" relevant="false" type="CLASS">amides</ne>, <ne type="ONT" id="WO2007045886.HC.class-names.79" epochem-id="EPOCHEM:NEW:CLASS:182" name="nitriles" comment="" chebi-id="CHEBI:18379" relevant="false">nitriles</ne> and <ne id="WO2007045886.HC.class-names.80" epochem-id="EPOCHEM:NEW:CLASS:183" name="ethers" comment="" chebi-id="CHEBI:25698" relevant="false" type="CLASS">ethers</ne>; <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.267" epochem-id="EPOCHEM:NEW:COMPOUND:814" name="vinyl pyridine" comment="" chebi-id="WO2007045886:22077" relevant="false">vinyl pyridine</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.268" epochem-id="EPOCHEM:NEW:COMPOUND:815" name="diethyl vinylphosphonate" comment="" chebi-id="WO2007045886:173629" relevant="false">diethyl vinylphosphonate</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.269" epochem-id="EPOCHEM:NEW:COMPOUND:816" name="sodium styrenesulfonate" comment="" chebi-id="WO2007045886:323072" relevant="false">sodium styrenesulfonate</ne>. Examples of the <ne type="ONT" id="WO2007045886.HC.class-names.285" epochem-id="EPOCHEM:NEW:CLASS:1095" name="nitroxide compounds" comment="" chebi-id="WO2007045886:796236" relevant="false">nitroxide compounds</ne> taught in this publication include <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.178" epochem-id="EPOCHEM:NEW:COMPOUND:812" name="4-allyloxy-TEMPO" comment="" chebi-id="WO2007045886:518160" relevant="false">4-allyloxy- TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.270" epochem-id="EPOCHEM:NEW:COMPOUND:817" name="4-(2-methoxyethoxy)-TEMPO" comment="" chebi-id="WO2007045886:309776" relevant="false">4-(2-methoxyethoxy)-TEMPO</ne>. US 6403850 discloses <ne id="WO2007045886.HC.class-names.290" epochem-id="EPOCHEM:NEW:CLASS:1096" name="nitroxide derivatives" comment="" chebi-id="WO2007045886:681891" relevant="false" type="CLASS">nitroxide derivatives</ne>, including <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.271" epochem-id="EPOCHEM:NEW:COMPOUND:818" name="4-carbomethoxy-TEMPO" comment="" chebi-id="WO2007045886:216584" relevant="false">4-carbomethoxy-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.272" epochem-id="EPOCHEM:NEW:COMPOUND:819" name="A- carboethoxy-TEMPO" comment="4-carboethoxy-TEMPO" chebi-id="WO2007045886:688349" relevant="false">A- carboethoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.274" epochem-id="EPOCHEM:NEW:COMPOUND:821" name="4-ethanoyloxy-TEMPO" comment="" chebi-id="WO2007045886:409287" relevant="false">4-ethanoyloxy-TEMPO</ne>, as being useful as inhibitors of premature polymerisation of ethylenically unsaturated monomers.
EP-A-0574666 describes the synthesis of various <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.275" epochem-id="EPOCHEM:NEW:COMPOUND:822" name="4-alkoxy-TEMPO" comment="" chebi-id="WO2007045886:808792" relevant="false">4-alkoxy-TEMPO</ne> compounds. In particular, this publication teaches the compounds <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.174" epochem-id="EPOCHEM:NEW:COMPOUND:811" name="4-methoxy-TEMPO" comment="" chebi-id="WO2007045886:176343" relevant="true">4-methoxy-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.278" epochem-id="EPOCHEM:NEW:COMPOUND:823" name="4-ethoxy-TEMPO" comment="" chebi-id="WO2007045886:376394" relevant="false">4-ethoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.280" epochem-id="EPOCHEM:NEW:COMPOUND:824" name="4-n-butoxy-TEMPO" comment="" chebi-id="WO2007045886:917430" relevant="false">4-n-butoxy-TEMPO</ne>.
US 5631366 teaches that <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.276" epochem-id="EPOCHEM:NEW:COMPOUND:822" name="4-alkoxy-TEMPO" comment="" chebi-id="WO2007045886:808792" relevant="false">4-alkoxy-TEMPO</ne> derivatives can be used as catalysts in the synthesis of <ne id="WO2007045886.HC.class-names.86" epochem-id="EPOCHEM:NEW:CLASS:184" name="3-formylcephem" comment="" chebi-id="WO2007045886:228436" relevant="false" type="CLASS">3-formylcephem</ne> derivatives. Specifically disclosed are <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.175" epochem-id="EPOCHEM:NEW:COMPOUND:811" name="4-methoxy-TEMPO" comment="" chebi-id="WO2007045886:176343" relevant="true">4-methoxy-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.6" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.273" epochem-id="EPOCHEM:NEW:COMPOUND:820" name="4-hexoxy-TEMPO" comment="" chebi-id="WO2007045886:977452" relevant="false">4-hexoxy-TEMPO</ne>.
JP-A-5320217 teaches that <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.277" epochem-id="EPOCHEM:NEW:COMPOUND:822" name="4-alkoxy-TEMPO" comment="" chebi-id="WO2007045886:808792" relevant="false">4-alkoxy-TEMPO</ne> compounds are useful in preventing polymerisation of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.361" epochem-id="EPOCHEM:COMPOUND:734" name="methacrylic acid" comment="" chebi-id="CHEBI:25219" relevant="false">methacrylic acid</ne> monomers when used in combination with <ne id="WO2007045886.HC.class-names.67" epochem-id="EPOCHEM:NEW:CLASS:179" name="phenothiazines" comment="" chebi-id="CHEBI:38093" relevant="false" type="CLASS">phenothiazines</ne>, aromatic <ne id="WO2007045886.HC.class-names.16" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne> of <ne id="WO2007045886.HC.class-names.291" epochem-id="EPOCHEM:NEW:CLASS:1097" name="phenolic compounds" comment="" chebi-id="WO2007045886:169669" relevant="false" type="CLASS">phenolic compounds</ne>. Specifically disclosed are <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.281" epochem-id="EPOCHEM:NEW:COMPOUND:825" name="A- methoxy-TEMPO" comment="4-methoxy-TEMPO" chebi-id="WO2007045886:477129" relevant="false">A- methoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.279" epochem-id="EPOCHEM:NEW:COMPOUND:823" name="4-ethoxy-TEMPO" comment="" chebi-id="WO2007045886:376394" relevant="false">4-ethoxy-TEMPO</ne>.
WO-A-98/56746 describes a composition for inhibiting the premature polymerisation of certain ethylenically unsaturated acrylate monomers. The composition comprises an ethylenically unsaturated acrylate monomer and a synergistic mixture of two <ne type="ONT" id="WO2007045886.HC.class-names.286" epochem-id="EPOCHEM:NEW:CLASS:1095" name="nitroxide compounds" comment="" chebi-id="WO2007045886:796236" relevant="false">nitroxide compounds</ne>. This publication describes a range of <ne type="ONT" id="WO2007045886.HC.class-names.287" epochem-id="EPOCHEM:NEW:CLASS:1095" name="nitroxide compounds" comment="" chebi-id="WO2007045886:796236" relevant="false">nitroxide compounds</ne>, including <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.282" epochem-id="EPOCHEM:NEW:COMPOUND:826" name="A- hydroxy-TEMPO" comment="4-hydroxy-TEMPO" chebi-id="WO2007045886:310400" relevant="false">A- hydroxy-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.283" epochem-id="EPOCHEM:NEW:COMPOUND:827" name="4-propoxy-TEMPO" comment="" chebi-id="WO2007045886:624" relevant="false">4-propoxy-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.284" epochem-id="EPOCHEM:NEW:COMPOUND:828" name="4-(2-methoxyethoxyacetoxy)-TEMPO" comment="" chebi-id="WO2007045886:323492" relevant="false">4-(2-methoxyethoxyacetoxy)-TEMPO</ne>.
The purification of ethylenically unsaturated monomers usually involves the partition of the monomers into organic and aqueous phases. Often, when a stable <ne id="WO2007045886.HC.class-names.349" epochem-id="EPOCHEM:NEW:CLASS:1098" name="nitroxide" comment="" chebi-id="WO2007045886:373788" relevant="false" type="CLASS">nitroxide</ne> inhibitor is used, the inhibitor only partitions sufficiently well into only one of the phases.
Compounds such as <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.112" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> have good <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.364" epochem-id="EPOCHEM:COMPOUND:5421" name="water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne> solubility but are generally poorly soluble in non-polar organic <ne type="ONT" id="WO2007045886.HC.class-names.219" epochem-id="EPOCHEM:NEW:CLASS:769" name="solvents" comment="" chebi-id="CHEBI:46787" relevant="false">solvents</ne>. As a result, premature polymerisation is only effectively inhibited in the aqueous phase, not the organic phase. There remains a need for compounds and compositions which allow for effective inhibition of polymerisation in both the aqueous and organic phases.
Summary of the Invention
The present invention is based in part on the discovery that, by using <ne type="LIGAND" id="WO2007045886.HC.ligand-names.244" epochem-id="EPOCHEM:NEW:LIGAND:550" name="hydrocarbyloxy" comment="" chebi-id="WO2007045886:176304" relevant="false">hydrocarbyloxy</ne> substituents at the 4-position, the miscibility of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.308" epochem-id="EPOCHEM:COMPOUND:1618" name="TEMPO" comment="" chebi-id="CHEBI:32849" relevant="false">TEMPO</ne> in organic <ne type="ONT" id="WO2007045886.HC.class-names.220" epochem-id="EPOCHEM:NEW:CLASS:769" name="solvents" comment="" chebi-id="CHEBI:46787" relevant="false">solvents</ne> may be significantly increased. Such derivatives may be effective at inhibiting the premature polymerisation of ethylenically unsaturated monomers, especially when used in combination with a more hydrophilic <ne id="WO2007045886.HC.class-names.173" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> such as <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.113" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne>.
According to a first aspect of the invention, a method of inhibiting polymerisation of an ethylenically unsaturated monomer comprises contacting the monomer with a compound of formula (I):
</P>
<P>[0017]
EMI4.1
(I) wherein
R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.193" epochem-id="EPOCHEM:NEW:LIGAND:141" name="C4-20 hydrocarbyl" comment="" chebi-id="WO2007045886:688833" relevant="false">C4-20 hydrocarbyl</ne>; and
R [iota]2 , R r&gt;3 , O R4 and R are independently each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.224" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne>.
A second aspect of the invention is a composition for inhibiting polymerisation of an ethylenically unsaturated monomer, which comprises first and second inhibitors of said polymerisation, wherein the first inhibitor is a first <ne id="WO2007045886.HC.class-names.174" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> and is of the formula (I), and the second inhibitor is, for example but not limited thereto, a second <ne id="WO2007045886.HC.class-names.175" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
Another aspect of the invention is the use of a compound of formula (I) as an inhibitor of polymerisation of an ethylenically unsaturated monomer.
Another aspect of the invention is the use of a composition of the invention, as an inhibitor of polymerisation of an ethylenically unsaturated monomer.
The present invention is particularly useful in inhibiting the polymerisation of monomers such as <ne id="WO2007045886.HC.class-names.165" epochem-id="EPOCHEM:NEW:CLASS:499" name="styrenes" comment="" chebi-id="CHEBI:26799" relevant="false" type="CLASS">styrenes</ne>, <ne id="WO2007045886.HC.class-names.398" epochem-id="EPOCHEM:NEW:CLASS:1099" name="vinyltoluenes" comment="" chebi-id="WO2007045886:138131" relevant="false" type="CLASS">vinyltoluenes</ne>, <ne id="WO2007045886.HC.class-names.158" epochem-id="EPOCHEM:NEW:CLASS:497" name="divinylbenzenes" comment="" chebi-id="WO2007045886:410477" relevant="false" type="CLASS">divinylbenzenes</ne>, <ne id="WO2007045886.HC.class-names.162" epochem-id="EPOCHEM:NEW:CLASS:498" name="dienes" comment="" chebi-id="WO2007045886:119665" relevant="false" type="CLASS">dienes</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.157" epochem-id="EPOCHEM:NEW:COMPOUND:810" name="butadiene" comment="" chebi-id="CHEBI:39479" relevant="false">butadiene</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.163" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>), <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.77" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne> and <ne id="WO2007045886.HC.class-names.75" epochem-id="EPOCHEM:NEW:CLASS:44" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.139" epochem-id="EPOCHEM:COMPOUND:7898" name="butyl acrylate" comment="" chebi-id="CHEBI:3245" relevant="false">butyl acrylate</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.145" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.131" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne>). Of particular mention are <ne id="WO2007045886.HC.class-names.224" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomers. Compounds of the present invention, particularly those wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.237" epochem-id="EPOCHEM:NEW:LIGAND:396" name="C4-6 hydrocarbyl" comment="" chebi-id="WO2007045886:892900" relevant="false">C4-6 hydrocarbyl</ne>, may be prepared in liquid form and thus may be easier and more environmentally acceptable compared with conventional solid inhibitors. Furthermore, the compounds may improve the solubility of monomers and/or other inhibitors in organic <ne type="ONT" id="WO2007045886.HC.class-names.221" epochem-id="EPOCHEM:NEW:CLASS:769" name="solvents" comment="" chebi-id="CHEBI:46787" relevant="false">solvents</ne>.
Description of Various Embodiments
The term "<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.310" epochem-id="EPOCHEM:COMPOUND:1618" name="TEMPO" comment="" chebi-id="CHEBI:32849" relevant="false">TEMPO</ne>" as used herein refers to <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.358" epochem-id="EPOCHEM:NEW:COMPOUND:829" name="2,2,6,6-tetramethy!piperidine~1-oxide" comment="2,2,6,6-tetramethylpiperidine-1-oxide" chebi-id="WO2007045886:493936" relevant="false">2,2,6,6-tetramethy!piperidine~1-oxide</ne>.
The term "ethylenically unsaturated monomer" as used herein refers to a monomer comprising at least one carbon-carbon double bond. Such a monomer may comprise an aliphatic and/or an aromatic moiety. Examples of such monomers include <ne id="WO2007045886.HC.class-names.166" epochem-id="EPOCHEM:NEW:CLASS:499" name="styrenes" comment="" chebi-id="CHEBI:26799" relevant="false" type="CLASS">styrenes</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.44" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.360" epochem-id="EPOCHEM:NEW:COMPOUND:802" name="styrene sulphonic acid" comment="" chebi-id="WO2007045886:5313" relevant="false">styrene sulphonic acid</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.71" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]-methylstyrene</ne>), <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.90" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, <ne id="WO2007045886.HC.class-names.159" epochem-id="EPOCHEM:NEW:CLASS:497" name="divinylbenzenes" comment="" chebi-id="WO2007045886:410477" relevant="false" type="CLASS">divinylbenzenes</ne> and <ne id="WO2007045886.HC.class-names.163" epochem-id="EPOCHEM:NEW:CLASS:498" name="dienes" comment="" chebi-id="WO2007045886:119665" relevant="false" type="CLASS">dienes</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.158" epochem-id="EPOCHEM:NEW:COMPOUND:810" name="butadiene" comment="" chebi-id="CHEBI:39479" relevant="false">butadiene</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.164" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>), <ne id="WO2007045886.HC.class-names.76" epochem-id="EPOCHEM:NEW:CLASS:44" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> (including <ne id="WO2007045886.HC.class-names.171" epochem-id="EPOCHEM:NEW:CLASS:772" name="acetates" comment="" chebi-id="WO2007045886:32197" relevant="false" type="CLASS">acetates</ne>, e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.132" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne>, and <ne id="WO2007045886.HC.class-names.168" epochem-id="EPOCHEM:NEW:CLASS:39" name="acrylates" comment="" chebi-id="WO2007045886:580199" relevant="false" type="CLASS">acrylates</ne>, e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.146" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.140" epochem-id="EPOCHEM:COMPOUND:7898" name="butyl acrylate" comment="" chebi-id="CHEBI:3245" relevant="false">butyl acrylate</ne>), <ne id="WO2007045886.HC.class-names.170" epochem-id="EPOCHEM:NEW:CLASS:500" name="acids" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acids</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.362" epochem-id="EPOCHEM:COMPOUND:734" name="methacrylic acid" comment="" chebi-id="CHEBI:25219" relevant="false">methacrylic acid</ne>), and the like.
The term "<ne id="WO2007045886.HC.class-names.172" epochem-id="EPOCHEM:NEW:CLASS:1008" name="ethylenicallyunsaturated hydrocarbon monomer" comment="" chebi-id="WO2007045886:638200" relevant="false" type="CLASS">ethylenically unsaturated hydrocarbon monomer</ne>" as used herein refers to a monomer comprising at least one carbon-carbon double bond and consisting exclusively of hydrogen and carbon atoms. Such a monomer may comprise an aliphatic and/or an aromatic moiety. Examples of such monomers include <ne id="WO2007045886.HC.class-names.167" epochem-id="EPOCHEM:NEW:CLASS:499" name="styrenes" comment="" chebi-id="CHEBI:26799" relevant="false" type="CLASS">styrenes</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.46" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.72" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]- methylstyrene</ne>), <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.91" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, <ne id="WO2007045886.HC.class-names.160" epochem-id="EPOCHEM:NEW:CLASS:497" name="divinylbenzenes" comment="" chebi-id="WO2007045886:410477" relevant="false" type="CLASS">divinylbenzenes</ne> and <ne id="WO2007045886.HC.class-names.164" epochem-id="EPOCHEM:NEW:CLASS:498" name="dienes" comment="" chebi-id="WO2007045886:119665" relevant="false" type="CLASS">dienes</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.159" epochem-id="EPOCHEM:NEW:COMPOUND:810" name="butadiene" comment="" chebi-id="CHEBI:39479" relevant="false">butadiene</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.165" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>) and the like.
The term "<ne type="LIGAND" id="WO2007045886.HC.ligand-names.196" epochem-id="EPOCHEM:NEW:LIGAND:142" name="C4-2Ohydrocarbyl" comment="" chebi-id="WO2007045886:330923" relevant="false">C4-2O hydrocarbyl</ne>" refers to a group consisting exclusively of hydrogen and carbon atoms, and which has 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 carbon atoms. Examples of such groups include <ne type="LIGAND" id="WO2007045886.HC.ligand-names.197" epochem-id="EPOCHEM:NEW:LIGAND:143" name="C4-I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:283447" relevant="false">C4-I0 alkyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.16" epochem-id="EPOCHEM:NEW:LIGAND:122" name="C4-I0alkenyl" comment="C4-C10 alkenyl" chebi-id="WO2007045886:141503" relevant="false">C4-I0 alkenyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.19" epochem-id="EPOCHEM:NEW:LIGAND:123" name="C4-10 alkynyl" comment="" chebi-id="WO2007045886:730270" relevant="false">C4-10 alkynyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.20" epochem-id="EPOCHEM:NEW:LIGAND:124" name="C4-I0 cycloalkyl" comment="C4-10 cycloalkyl" chebi-id="WO2007045886:497246" relevant="false">C4-I0 cycloalkyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.245" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>, -C%i0 alkyl-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.246" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> and -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.283" epochem-id="EPOCHEM:NEW:LIGAND:607" name="C1-I0alkyl" comment="C1-10 alkyl" chebi-id="WO2007045886:812" relevant="false">C1-I0 alkyl</ne>-C^o <ne type="LIGAND" id="WO2007045886.HC.ligand-names.127" epochem-id="EPOCHEM:NEW:LIGAND:133" name="cycloalkyl" comment="" chebi-id="CHEBI:3366" relevant="false">cycloalkyl</ne>.
The term "<ne type="LIGAND" id="WO2007045886.HC.ligand-names.225" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne>" as used refers to a straight or branched chain alkyl moiety having from 1 , 2, 3, 4, 5 or 6 carbon atoms. This term refers to groups such as <ne type="LIGAND" id="WO2007045886.HC.ligand-names.22" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.28" epochem-id="EPOCHEM:NEW:LIGAND:125" name="ethyl" comment="" chebi-id="CHEBI:37807" relevant="false">ethyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.120" epochem-id="EPOCHEM:NEW:LIGAND:132" name="propyl" comment="" chebi-id="CHEBI:26308" relevant="false">propyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.38" epochem-id="EPOCHEM:NEW:LIGAND:15" name="n-propyl" comment="" chebi-id="CHEBI:26308" relevant="false">n-propyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.41" epochem-id="EPOCHEM:NEW:LIGAND:126" name="isopropyl" comment="" chebi-id="CHEBI:30353" relevant="false">isopropyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.86" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.44" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.53" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.62" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.71" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.79" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne> and the like. The term "<ne type="LIGAND" id="WO2007045886.HC.ligand-names.198" epochem-id="EPOCHEM:NEW:LIGAND:143" name="C4-I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:283447" relevant="false">C4-I0 alkyl</ne>" as used herein refers to a straight or branched chain alkyl moiety having 4, 5, 6, 7, 8, 9 or 10 carbon atoms. This term refers to groups such as <ne type="LIGAND" id="WO2007045886.HC.ligand-names.90" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.45" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n- butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.54" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.63" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.72" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.80" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.202" epochem-id="EPOCHEM:NEW:LIGAND:144" name="heptyl" comment="" chebi-id="CHEBI:24526" relevant="false">heptyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.206" epochem-id="EPOCHEM:NEW:LIGAND:145" name="octyl" comment="" chebi-id="CHEBI:25657" relevant="false">octyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.209" epochem-id="EPOCHEM:NEW:LIGAND:146" name="nonyl" comment="" chebi-id="CHEBI:25589" relevant="false">nonyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.211" epochem-id="EPOCHEM:NEW:LIGAND:147" name="decyl" comment="" chebi-id="CHEBI:23580" relevant="false">decyl</ne> and the like.
The term "<ne type="LIGAND" id="WO2007045886.HC.ligand-names.17" epochem-id="EPOCHEM:NEW:LIGAND:122" name="C4-I0alkenyl" comment="C4-C10 alkenyl" chebi-id="WO2007045886:141503" relevant="false">C4-I0 alkenyl</ne>" as used herein refers to a straight or branched chain <ne type="LIGAND" id="WO2007045886.HC.ligand-names.265" epochem-id="EPOCHEM:NEW:LIGAND:551" name="alkenyl" comment="" chebi-id="CHEBI:37614" relevant="false">alkenyl</ne> moiety having 4, 5, 6, 7, 8, 9 or 10 carbon atoms. This term refers to groups such as <ne type="LIGAND" id="WO2007045886.HC.ligand-names.1" epochem-id="EPOCHEM:NEW:LIGAND:113" name="1- methylprop-1en-1-yl" comment="1- methylprop-1-en-1-yl" chebi-id="WO2007045886:765233" relevant="false">1- methylprop-1en-1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.2" epochem-id="EPOCHEM:NEW:LIGAND:114" name="2-methylprop-1-en-1-yl" comment="" chebi-id="WO2007045886:147403" relevant="false">2-methylprop-1-en-1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.3" epochem-id="EPOCHEM:NEW:LIGAND:115" name="1-methylprop-2-en-1-yl" comment="" chebi-id="WO2007045886:814148" relevant="false">1-methylprop-2-en-1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.5" epochem-id="EPOCHEM:NEW:LIGAND:116" name="2-methylprop-2-en- 1-yl" comment="" chebi-id="WO2007045886:590091" relevant="false">2-methylprop-2-en- 1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.6" epochem-id="EPOCHEM:NEW:LIGAND:117" name="penten-1-yl, penten-2-yl" comment="" chebi-id="WO2007045886:476485" relevant="false">penten-1-yl, penten-2-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.8" epochem-id="EPOCHEM:NEW:LIGAND:118" name="penten-3-yl" comment="" chebi-id="WO2007045886:945209" relevant="false">penten-3-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.10" epochem-id="EPOCHEM:NEW:LIGAND:119" name="penten-4-yl" comment="" chebi-id="WO2007045886:401935" relevant="false">penten-4-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.12" epochem-id="EPOCHEM:NEW:LIGAND:120" name="1-methylbut-1-en-1-yl" comment="" chebi-id="WO2007045886:553487" relevant="false">1-methylbut-1-en-1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.14" epochem-id="EPOCHEM:NEW:LIGAND:121" name="2- methylbut-1-en-1-yl" comment="" chebi-id="WO2007045886:931887" relevant="false">2- methylbut-1-en-1-yl</ne> and the like.
The term "<ne type="LIGAND" id="WO2007045886.HC.ligand-names.21" epochem-id="EPOCHEM:NEW:LIGAND:124" name="C4-I0 cycloalkyl" comment="C4-10 cycloalkyl" chebi-id="WO2007045886:497246" relevant="false">C4-I0 cycloalkyl</ne>" as used herein refers to an alicyclic moiety having 4, 5, 6, 7, 8, 9 or 10 carbon atoms. The group may be a monocyclic, polycyclic, fused or bridged ring system. This term includes reference to groups such as <ne type="LIGAND" id="WO2007045886.HC.ligand-names.213" epochem-id="EPOCHEM:NEW:LIGAND:148" name="cyclobutyl" comment="" chebi-id="CHEBI:30376" relevant="false">cyclobutyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.214" epochem-id="EPOCHEM:NEW:LIGAND:104" name="cyclopentyl" comment="" chebi-id="WO2007045886:418782" relevant="false">cyclopentyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.215" epochem-id="EPOCHEM:NEW:LIGAND:106" name="cyclohexyl" comment="" chebi-id="WO2007045886:294415" relevant="false">cyclohexyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.216" epochem-id="EPOCHEM:NEW:LIGAND:149" name="cycloheptyl" comment="" chebi-id="WO2007045886:776421" relevant="false">cycloheptyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.217" epochem-id="EPOCHEM:NEW:LIGAND:150" name="cyclooctyl" comment="" chebi-id="WO2007045886:704098" relevant="false">cyclooctyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.218" epochem-id="EPOCHEM:NEW:LIGAND:151" name="cyclononyl" comment="" chebi-id="WO2007045886:18230" relevant="false">cyclononyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.219" epochem-id="EPOCHEM:NEW:LIGAND:152" name="cyclodecyl" comment="" chebi-id="WO2007045886:611090" relevant="false">cyclodecyl</ne> and the like.
The term "<ne type="LIGAND" id="WO2007045886.HC.ligand-names.247" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>" as used herein refers to an aromatic ring system comprising 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 ring carbon atoms. The group is often <ne type="LIGAND" id="WO2007045886.HC.ligand-names.170" epochem-id="EPOCHEM:NEW:LIGAND:108" name="phenyl" comment="" chebi-id="CHEBI:30396" relevant="false">phenyl</ne> but may be a polycyclic ring system, having two or more rings, at least one of which is aromatic. This term includes reference to groups such as <ne type="LIGAND" id="WO2007045886.HC.ligand-names.171" epochem-id="EPOCHEM:NEW:LIGAND:108" name="phenyl" comment="" chebi-id="CHEBI:30396" relevant="false">phenyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.173" epochem-id="EPOCHEM:NEW:LIGAND:140" name="naphthyl" comment="" chebi-id="WO2007045886:438425" relevant="false">naphthyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.220" epochem-id="EPOCHEM:NEW:LIGAND:153" name="fluorenyl" comment="" chebi-id="WO2007045886:239268" relevant="false">fluorenyl</ne> and the like.
The term "substituted" as used herein in reference to a moiety or group means that one or more hydrogen atoms in the respective moiety, especially up to 5, more especially 1 , 2 or 3 of the hydrogen atoms are replaced independently of each other by the corresponding number of the described substituents. It will, of course, be understood that substituents are only at positions where they are chemically possible, the person skilled in the art being able to decide (either experimentally or theoretically) without inappropriate effort whether a particular substitution is possible. Additionally, it will of course be understood that the substituents described herein may themselves be substituted by any substituent, subject to the aforementioned restriction to appropriate substitutions as recognised by the skilled man.
Embodiments of the invention are described below. It will be appreciated that the features specified in each embodiment may be combined with other specified features, to provide further embodiments.
The present invention involves the use of a compound of formula (I):
EMI7.1
(I) wherein
R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.221" epochem-id="EPOCHEM:NEW:LIGAND:154" name="C4-10 hydrocarbyl" comment="" chebi-id="WO2007045886:95751" relevant="false">C4-10 hydrocarbyl</ne>; and
R&lt;2&gt;, R&lt;3&gt;, R&lt;4&gt; and R&lt;5&gt; are independently each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.155" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>.
R&lt;2&gt;, R&lt;3&gt;, R&lt;4&gt; and R&lt;5&gt; may be independently selected from <ne type="LIGAND" id="WO2007045886.HC.ligand-names.23" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.29" epochem-id="EPOCHEM:NEW:LIGAND:125" name="ethyl" comment="" chebi-id="CHEBI:37807" relevant="false">ethyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.122" epochem-id="EPOCHEM:NEW:LIGAND:132" name="propyl" comment="" chebi-id="CHEBI:26308" relevant="false">propyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.39" epochem-id="EPOCHEM:NEW:LIGAND:15" name="n-propyl" comment="" chebi-id="CHEBI:26308" relevant="false">n-propyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.42" epochem-id="EPOCHEM:NEW:LIGAND:126" name="isopropyl" comment="" chebi-id="CHEBI:30353" relevant="false">isopropyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.94" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.46" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.55" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.64" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.73" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne> and <ne type="LIGAND" id="WO2007045886.HC.ligand-names.81" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne>.
In one embodiment, R&lt;2&gt;, R&lt;3&gt;, R&lt;4&gt; and R&lt;5&gt; are each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.24" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>, i.e. the compound is of the formula (II):
</P>
<P>[0042]
EMI7.2
(H)
In one embodiment of the invention, R&lt;1&gt; is a <ne type="LIGAND" id="WO2007045886.HC.ligand-names.222" epochem-id="EPOCHEM:NEW:LIGAND:154" name="C4-10 hydrocarbyl" comment="" chebi-id="WO2007045886:95751" relevant="false">C4-10 hydrocarbyl</ne> group comprising an <ne type="LIGAND" id="WO2007045886.HC.ligand-names.276" epochem-id="EPOCHEM:NEW:LIGAND:552" name="aliphatic hydrocarbon group" comment="" chebi-id="WO2007045886:834041" relevant="false">aliphatic hydrocarbon group</ne> (e.g. <ne type="LIGAND" id="WO2007045886.HC.ligand-names.226" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.223" epochem-id="EPOCHEM:NEW:LIGAND:155" name="C4-10 alkyl" comment="" chebi-id="WO2007045886:695092" relevant="false">C4-10 alkyl</ne>) optionally substituted with a <ne type="LIGAND" id="WO2007045886.HC.ligand-names.279" epochem-id="EPOCHEM:NEW:LIGAND:553" name="cyclic hydrocarbon group" comment="" chebi-id="WO2007045886:555983" relevant="false">cyclic hydrocarbon group</ne> (e.g. <ne type="LIGAND" id="WO2007045886.HC.ligand-names.129" epochem-id="EPOCHEM:NEW:LIGAND:133" name="cycloalkyl" comment="" chebi-id="CHEBI:3367" relevant="false">cycloalkyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.248" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>).
In another embodiment, R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.199" epochem-id="EPOCHEM:NEW:LIGAND:143" name="C4-I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:283447" relevant="false">C4-I0 alkyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.166" epochem-id="EPOCHEM:NEW:LIGAND:137" name="C4-10 alkenyl" comment="" chebi-id="WO2007045886:608918" relevant="false">C4-10 alkenyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.249" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> or -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.156" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.250" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>, wherein <ne type="LIGAND" id="WO2007045886.HC.ligand-names.251" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> and -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.227" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.252" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> are optionally substituted with <ne type="LIGAND" id="WO2007045886.HC.ligand-names.228" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.148" epochem-id="EPOCHEM:NEW:LIGAND:134" name="C2-6 alkenyl" comment="" chebi-id="WO2007045886:148772" relevant="false">C2-6 alkenyl</ne>.
In a further embodiment, R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.234" epochem-id="EPOCHEM:NEW:LIGAND:158" name="C4--I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:833515" relevant="false">C4--I0 alkyl</ne>, for example <ne type="LIGAND" id="WO2007045886.HC.ligand-names.98" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.47" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.56" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.65" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert- butyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.74" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.82" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.203" epochem-id="EPOCHEM:NEW:LIGAND:144" name="heptyl" comment="" chebi-id="CHEBI:24526" relevant="false">heptyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.207" epochem-id="EPOCHEM:NEW:LIGAND:145" name="octyl" comment="" chebi-id="CHEBI:25657" relevant="false">octyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.210" epochem-id="EPOCHEM:NEW:LIGAND:146" name="nonyl" comment="" chebi-id="CHEBI:25589" relevant="false">nonyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.212" epochem-id="EPOCHEM:NEW:LIGAND:147" name="decyl" comment="" chebi-id="CHEBI:23580" relevant="false">decyl</ne>. More preferably, R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.48" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.57" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.66" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.75" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.83" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.204" epochem-id="EPOCHEM:NEW:LIGAND:144" name="heptyl" comment="" chebi-id="CHEBI:24526" relevant="false">heptyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.208" epochem-id="EPOCHEM:NEW:LIGAND:145" name="octyl" comment="" chebi-id="CHEBI:25657" relevant="false">octyl</ne>, in particular <ne type="LIGAND" id="WO2007045886.HC.ligand-names.49" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.58" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.67" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert- butyl</ne>.
In a further embodiment, R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.167" epochem-id="EPOCHEM:NEW:LIGAND:137" name="C4-10 alkenyl" comment="" chebi-id="WO2007045886:608918" relevant="false">C4-10 alkenyl</ne>, for example C4, C5, C6, C7 or C8 <ne type="LIGAND" id="WO2007045886.HC.ligand-names.269" epochem-id="EPOCHEM:NEW:LIGAND:551" name="alkenyl" comment="" chebi-id="CHEBI:37614" relevant="false">alkenyl</ne>. In particular, R&lt;1&gt; may be <ne type="LIGAND" id="WO2007045886.HC.ligand-names.168" epochem-id="EPOCHEM:NEW:LIGAND:138" name="1-methy!prop-1-en-1-yl" comment="1-methylprop-1-en-1-yl" chebi-id="WO2007045886:272232" relevant="false">1-methy!prop-1-en-1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.169" epochem-id="EPOCHEM:NEW:LIGAND:139" name="2-methylprop-1~en-1-yl" comment="2-methylprop-1-en-1-yl" chebi-id="WO2007045886:516800" relevant="false">2-methylprop-1~en-1-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.4" epochem-id="EPOCHEM:NEW:LIGAND:115" name="1-methylprop-2-en-1-yl" comment="" chebi-id="WO2007045886:814148" relevant="false">1-methylprop-2- en-1-yl</ne>, 2-methyIprop-2-en-1-yl, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.7" epochem-id="EPOCHEM:NEW:LIGAND:117" name="penten-1-yl, penten-2-yl" comment="" chebi-id="WO2007045886:476485" relevant="false">penten-1-yl, penten-2-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.9" epochem-id="EPOCHEM:NEW:LIGAND:118" name="penten-3-yl" comment="" chebi-id="WO2007045886:945209" relevant="false">penten-3-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.11" epochem-id="EPOCHEM:NEW:LIGAND:119" name="penten-4-yl" comment="" chebi-id="WO2007045886:401935" relevant="false">penten-4-yl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.13" epochem-id="EPOCHEM:NEW:LIGAND:120" name="1-methylbut-1-en-1-yl" comment="" chebi-id="WO2007045886:553487" relevant="false">1- methylbut-1-en-1-yl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.15" epochem-id="EPOCHEM:NEW:LIGAND:121" name="2- methylbut-1-en-1-yl" comment="" chebi-id="WO2007045886:931887" relevant="false">2-methylbut-1-en-1-yl</ne>.
In a further embodiment, R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.253" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>, for example <ne type="LIGAND" id="WO2007045886.HC.ligand-names.172" epochem-id="EPOCHEM:NEW:LIGAND:108" name="phenyl" comment="" chebi-id="CHEBI:30396" relevant="false">phenyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.174" epochem-id="EPOCHEM:NEW:LIGAND:140" name="naphthyl" comment="" chebi-id="WO2007045886:438425" relevant="false">naphthyl</ne>, either of which may be substituted with one or more substituents selected from Ci-6 alky! (e.g. <ne type="LIGAND" id="WO2007045886.HC.ligand-names.25" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.30" epochem-id="EPOCHEM:NEW:LIGAND:125" name="ethyl" comment="" chebi-id="CHEBI:37807" relevant="false">ethyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.149" epochem-id="EPOCHEM:NEW:LIGAND:134" name="C2-6 alkenyl" comment="" chebi-id="WO2007045886:148772" relevant="false">C2-6 alkenyl</ne> and <ne type="LIGAND" id="WO2007045886.HC.ligand-names.153" epochem-id="EPOCHEM:NEW:LIGAND:135" name="C2-6 alkynyl" comment="" chebi-id="WO2007045886:693148" relevant="false">C2-6 alkynyl</ne>.
In a further embodiment, R&lt;1&gt; is -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.229" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.254" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> optionally substituted with <ne type="LIGAND" id="WO2007045886.HC.ligand-names.157" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.150" epochem-id="EPOCHEM:NEW:LIGAND:134" name="C2-6 alkenyl" comment="" chebi-id="WO2007045886:148772" relevant="false">C2-6 alkenyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.154" epochem-id="EPOCHEM:NEW:LIGAND:135" name="C2-6 alkynyl" comment="" chebi-id="WO2007045886:693148" relevant="false">C2-6 alkynyl</ne>.
A particular <ne id="WO2007045886.HC.class-names.176" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.1" epochem-id="EPOCHEM:NEW:COMPOUND:795" name="4-butoxy-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:862533" relevant="true">4-butoxy-2,2,6,6-tetramethylpiperidine-1 -oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.7" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4- butoxy-TEMPO</ne>").
The <ne id="WO2007045886.HC.class-names.177" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> may be used in combination with a second inhibitor of polymerisation. The invention therefore provides methods and compositions in which the <ne id="WO2007045886.HC.class-names.178" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is used in combination with a second inhibitor of polymerisation. The second inhibitor is preferably more hydrophilic than the <ne id="WO2007045886.HC.class-names.179" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
In a particular embodiment, the <ne id="WO2007045886.HC.class-names.180" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is used in combination with a second <ne id="WO2007045886.HC.class-names.181" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> which is an inhibitor of premature monomer polymerisation. The second <ne id="WO2007045886.HC.class-names.182" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> may be present in a composition comprising the first <ne id="WO2007045886.HC.class-names.183" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
The second <ne id="WO2007045886.HC.class-names.184" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is preferably more hydrophilic (i.e. more oleophobic, having a greater solubility in aqueous media such as <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.365" epochem-id="EPOCHEM:COMPOUND:5421" name="water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne>) than the first <ne id="WO2007045886.HC.class-names.185" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
In one embodiment, the second <ne id="WO2007045886.HC.class-names.186" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is a compound of formula (III):
EMI9.1
(III) wherein
</P>
<P>1.
R is an atom or group which is more hydrophilic than -OR ; and
R &lt;-&gt;J', R-&gt;8&lt;B&gt;, R i-&gt;9&lt;a&gt; and R&lt;1U&gt; are each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.158" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>.
In one embodiment, R&lt;7&gt;, R&lt;8&gt;, R&lt;9&gt; and R&lt;10&gt; are each independently selected from <ne type="LIGAND" id="WO2007045886.HC.ligand-names.26" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.31" epochem-id="EPOCHEM:NEW:LIGAND:125" name="ethyl" comment="" chebi-id="CHEBI:37807" relevant="false">ethyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.124" epochem-id="EPOCHEM:NEW:LIGAND:132" name="propyl" comment="" chebi-id="CHEBI:26308" relevant="false">propyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.40" epochem-id="EPOCHEM:NEW:LIGAND:15" name="n-propyl" comment="" chebi-id="CHEBI:26308" relevant="false">n-propyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.43" epochem-id="EPOCHEM:NEW:LIGAND:126" name="isopropyl" comment="" chebi-id="CHEBI:30353" relevant="false">isopropyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.108" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne> (<ne type="LIGAND" id="WO2007045886.HC.ligand-names.50" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.59" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.68" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>), <ne type="LIGAND" id="WO2007045886.HC.ligand-names.76" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne> and <ne type="LIGAND" id="WO2007045886.HC.ligand-names.84" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne>.
In another embodiment, R&lt;7&gt;, R&lt;8&gt;, R&lt;9&gt; and R&lt;10&gt; are each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.27" epochem-id="EPOCHEM:NEW:LIGAND:13" name="methyl" comment="" chebi-id="CHEBI:29309" relevant="false">methyl</ne>, i.e. the second <ne id="WO2007045886.HC.class-names.187" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is of the formula (IV):
</P>
<P>[0061]
EMI9.2
(IV)
In a particular embodiment, R is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.282" epochem-id="EPOCHEM:NEW:LIGAND:1" name="hydroxyl" comment="" chebi-id="CHEBI:29191" relevant="false">hydroxyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.240" epochem-id="EPOCHEM:NEW:LIGAND:8" name="oxo" comment="" chebi-id="CHEBI:46629" relevant="false">oxo</ne>.
The second <ne id="WO2007045886.HC.class-names.188" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> may be <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.30" epochem-id="EPOCHEM:NEW:COMPOUND:797" name="4-hydroxy- 2,2,6,6-tetramethylpiperidine-1-oxide" comment="" chebi-id="WO2007045886:624799" relevant="true">4-hydroxy-2,2,6,6-tetramethylpiperidine-1 -oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.114" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne>").
Alternatively, the second <ne id="WO2007045886.HC.class-names.189" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> may be <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.101" epochem-id="EPOCHEM:NEW:COMPOUND:803" name="4-oxo-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:340917" relevant="true">4-oxo-2,2,6,6- tetramethylpiperidine-1 -oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.107" epochem-id="EPOCHEM:NEW:COMPOUND:805" name="4-oxo-TEMPO" comment="" chebi-id="WO2007045886:773595" relevant="false">4-oxo-TEMPO</ne>").
In a preferred embodiment, the first <ne id="WO2007045886.HC.class-names.190" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.8" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne>, and the second <ne id="WO2007045886.HC.class-names.191" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.115" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne>. Alternatively or additionally, the invention may involve the use of one or more inhibitors selected from <ne id="WO2007045886.HC.class-names.57" epochem-id="EPOCHEM:NEW:CLASS:178" name="phenols" comment="" chebi-id="CHEBI:33853" relevant="false" type="CLASS">phenols</ne>, <ne id="WO2007045886.HC.class-names.52" epochem-id="EPOCHEM:NEW:CLASS:177" name="alkylated phenols" comment="" chebi-id="WO2007045886:532770" relevant="false" type="CLASS">alkylated phenols</ne>, <ne id="WO2007045886.HC.class-names.32" epochem-id="EPOCHEM:NEW:CLASS:173" name="nitrophenols" comment="" chebi-id="CHEBI:25562" relevant="false" type="CLASS">nitrophenols</ne>, <ne id="WO2007045886.HC.class-names.37" epochem-id="EPOCHEM:NEW:CLASS:174" name="nitrosophenols" comment="" chebi-id="WO2007045886:904246" relevant="false" type="CLASS">nitrosophenols</ne>, <ne id="WO2007045886.HC.class-names.42" epochem-id="EPOCHEM:NEW:CLASS:175" name="quinones" comment="" chebi-id="CHEBI:36141" relevant="false" type="CLASS">quinones</ne>, <ne id="WO2007045886.HC.class-names.47" epochem-id="EPOCHEM:NEW:CLASS:176" name="hydroquinones" comment="" chebi-id="CHEBI:24646" relevant="false" type="CLASS">hydroquinones</ne>, <ne id="WO2007045886.HC.class-names.11" epochem-id="EPOCHEM:NEW:CLASS:169" name="quinone ethers" comment="" chebi-id="WO2007045886:299220" relevant="false" type="CLASS">quinone ethers</ne>, <ne id="WO2007045886.HC.class-names.17" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne>, <ne id="WO2007045886.HC.class-names.68" epochem-id="EPOCHEM:NEW:CLASS:179" name="phenothiazines" comment="" chebi-id="CHEBI:38093" relevant="false" type="CLASS">phenothiazines</ne>, <ne id="WO2007045886.HC.class-names.22" epochem-id="EPOCHEM:NEW:CLASS:171" name="hydroxylamines" comment="" chebi-id="CHEBI:24709" relevant="false" type="CLASS">hydroxylamines</ne> and <ne id="WO2007045886.HC.class-names.27" epochem-id="EPOCHEM:NEW:CLASS:172" name="quinone methides" comment="" chebi-id="WO2007045886:173453" relevant="false" type="CLASS">quinone methides</ne>. These compounds may be used in combination with the first <ne id="WO2007045886.HC.class-names.192" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> and, in place of or in addition to, the optional second <ne id="WO2007045886.HC.class-names.193" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>. Of particular mention are <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.34" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne> and alkoxylated phenol compounds (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.154" epochem-id="EPOCHEM:NEW:COMPOUND:809" name="4- methoxyphenol" comment="" chebi-id="WO2007045886:849401" relevant="false">4- methoxyphenol</ne>).
The ethylenically unsaturated monomer may be, for example, a <ne id="WO2007045886.HC.class-names.226" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomer such as a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.47" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.48" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.73" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]-methylstyrene</ne>), <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.78" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.92" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.96" epochem-id="EPOCHEM:NEW:COMPOUND:801" name="divinylbenzene" comment="" chebi-id="WO2007045886:746072" relevant="false">divinylbenzene</ne> or a <ne id="WO2007045886.HC.class-names.399" epochem-id="EPOCHEM:NEW:CLASS:1100" name="diene" comment="" chebi-id="WO2007045886:811490" relevant="false" type="CLASS">diene</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.160" epochem-id="EPOCHEM:NEW:COMPOUND:810" name="butadiene" comment="" chebi-id="CHEBI:39479" relevant="false">butadiene</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.166" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>). Other monomers include <ne id="WO2007045886.HC.class-names.77" epochem-id="EPOCHEM:NEW:CLASS:44" name="esters" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">esters</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.133" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.141" epochem-id="EPOCHEM:COMPOUND:7898" name="butyl acrylate" comment="" chebi-id="CHEBI:3245" relevant="false">butyl acrylate</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.147" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne>). In a particular embodiment, the monomer is a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.49" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.50" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>) or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.79" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>. The monomer may be present in a mixture with one or more comonomers.
A composition of the invention may comprise an ethylenically unsaturated monomer, in particular a <ne id="WO2007045886.HC.class-names.227" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomer. Again, the ethylenically unsaturated monomer may be a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.51" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.52" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.53" epochem-id="EPOCHEM:NEW:COMPOUND:802" name="styrene sulphonic acid" comment="" chebi-id="WO2007045886:5313" relevant="false">styrene</ne> sulphonic acid or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.74" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]-methylstyrene</ne>), <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.80" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.93" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.97" epochem-id="EPOCHEM:NEW:COMPOUND:801" name="divinylbenzene" comment="" chebi-id="WO2007045886:746072" relevant="false">divinylbenzene</ne>, a <ne id="WO2007045886.HC.class-names.400" epochem-id="EPOCHEM:NEW:CLASS:1100" name="diene" comment="" chebi-id="WO2007045886:811490" relevant="false" type="CLASS">diene</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.161" epochem-id="EPOCHEM:NEW:COMPOUND:810" name="butadiene" comment="" chebi-id="CHEBI:39479" relevant="false">butadiene</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.167" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>), or an <ne id="WO2007045886.HC.class-names.87" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.134" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.142" epochem-id="EPOCHEM:COMPOUND:7898" name="butyl acrylate" comment="" chebi-id="CHEBI:3245" relevant="false">butyl acrylate</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.148" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne>). In a particular embodiment, the composition comprises a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.54" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> (e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.55" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>) or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.81" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>. The composition may optionally comprise one or more comonomers.
A composition of the invention may comprise a solvent, e.g. an organic solvent. Of particular mention are non-polar organic <ne type="ONT" id="WO2007045886.HC.class-names.222" epochem-id="EPOCHEM:NEW:CLASS:769" name="solvents" comment="" chebi-id="CHEBI:46787" relevant="false">solvents</ne>, e.g. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.169" epochem-id="EPOCHEM:COMPOUND:5627" name="ethylbenzene" comment="" chebi-id="CHEBI:16101" relevant="false">ethylbenzene</ne>.
The amount of the or each <ne id="WO2007045886.HC.class-names.194" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> present may be varied according to the conditions and the type of monomer present.
For the purposes of illustration, the or each compound may be present in amount of from about 1 to about 1000 ppm (relative to the amount of monomer), more preferably from about 5 to about 500 ppm, more preferably still from about 10 to about 100 ppm. In one embodiment of the invention, the first <ne id="WO2007045886.HC.class-names.195" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is present in an amount of from about 60 to about 80 ppm, and the second <ne id="WO2007045886.HC.class-names.196" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is present in an amount of from about 5 to about 15 ppm. The inhibitor or inhibitor composition may be brought into contact with monomer by any conventional method. It may be added as a concentrate solution in suitable <ne type="ONT" id="WO2007045886.HC.class-names.223" epochem-id="EPOCHEM:NEW:CLASS:769" name="solvents" comment="" chebi-id="CHEBI:46787" relevant="false">solvents</ne> just upstream of the point of desired application by any suitable means. In addition, these compounds may be injected separately into the extraction or distillation train along with the incoming feed, or through separate entry points providing efficient distribution of the inhibitor composition. Since the inhibitor is gradually depleted during operation, it is generally necessary to maintain the appropriate amount of the inhibitor in the extraction or distillation apparatus by adding inhibitor during the course of the extraction or distillation process. Such addition may be carried out either on a generally continuous basis or it may consist of intermittently charging inhibitor into the extraction or distillation system if the concentration of inhibitor is to be maintained above the minimum required level.
Processes for obtaining the <ne type="ONT" id="WO2007045886.HC.class-names.288" epochem-id="EPOCHEM:NEW:CLASS:1095" name="nitroxide compounds" comment="" chebi-id="WO2007045886:796236" relevant="false">nitroxide compounds</ne> of the invention are well known in the art and will be apparent to the skilled person; see, for example, the teachings of EP-A- 0574666, US 5631366, JP-A-5320217 and WO-A-98/56746. By way of example, the compounds may be obtained by reacting R&lt;1&gt;Br with <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.116" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> in a nucleophilic substitution reaction, conducted in the presence of, for example, aqueous <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.369" epochem-id="EPOCHEM:COMPOUND:7174" name="sodium hydroxide" comment="" chebi-id="CHEBI:32145" relevant="false">sodium hydroxide</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.370" epochem-id="EPOCHEM:COMPOUND:5618" name="toluene" comment="" chebi-id="CHEBI:17578" relevant="false">toluene</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.373" epochem-id="EPOCHEM:NEW:COMPOUND:2057" name="Bu4NBr" comment="" chebi-id="WO2007045886:268944" relevant="false">Bu4NBr</ne>.
The following Examples illustrate the invention.
Example 1
The solubilities of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.108" epochem-id="EPOCHEM:NEW:COMPOUND:805" name="4-oxo-TEMPO" comment="" chebi-id="WO2007045886:773595" relevant="false">4-oxo-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.117" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.9" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.366" epochem-id="EPOCHEM:COMPOUND:5421" name="water" comment="" chebi-id="CHEBI:15377" relevant="false">water</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.371" epochem-id="EPOCHEM:COMPOUND:5618" name="toluene" comment="" chebi-id="CHEBI:17578" relevant="false">toluene</ne> were tested by preparing saturated solutions and measuring the amounts dissolved.
The solubilities of the compounds are given in Table 1. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.10" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> was found to have a greater solubility in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.372" epochem-id="EPOCHEM:COMPOUND:5618" name="toluene" comment="" chebi-id="CHEBI:17578" relevant="false">toluene</ne> than the 4-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.241" epochem-id="EPOCHEM:NEW:LIGAND:8" name="oxo" comment="" chebi-id="CHEBI:46629" relevant="false">oxo</ne>- and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.118" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> compounds.
</P>
<P>[0076]
EMI12.1
Table 1
Example 2
The evaluation of the efficacy of a selection of <ne type="ONT" id="WO2007045886.HC.class-names.289" epochem-id="EPOCHEM:NEW:CLASS:1095" name="nitroxide compounds" comment="" chebi-id="WO2007045886:796236" relevant="false">nitroxide compounds</ne> of the invention was carried out using a continuous stirred tank reactor (CSTR) which mimicked the re-boiler of a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.56" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> distillation column. The <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.57" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> had a residence time of approximately 2 hours inside the reactor and, at 110&lt;0&gt;C, the CSTR dead volume was 180 ml. A steady state was reached in four hours using a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.58" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> flow rate of 90 ml/hr. Data gathered after this point was averaged to give the steady state polymer level. <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.377" epochem-id="EPOCHEM:NEW:COMPOUND:749" name="Nitrogen" comment="" chebi-id="CHEBI:25555" relevant="false">Nitrogen</ne> sparging to remove <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.376" epochem-id="EPOCHEM:NEW:COMPOUND:318" name="oxygen" comment="" chebi-id="CHEBI:25805" relevant="false">oxygen</ne> gas was carried out at a measured rate of 200 ml/minute. Apart from the inhibitors, the only variable was the inherent variation in the rate of thermal initiation of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.59" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> polymerisation. The <ne id="WO2007045886.HC.class-names.73" epochem-id="EPOCHEM:NEW:CLASS:180" name="nitroxides" comment="" chebi-id="CHEBI:39477" relevant="false" type="CLASS">nitroxides</ne> tested were <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.176" epochem-id="EPOCHEM:NEW:COMPOUND:811" name="4-methoxy-TEMPO" comment="" chebi-id="WO2007045886:176343" relevant="true">4-methoxy-TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.119" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy- TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.324" epochem-id="EPOCHEM:COMPOUND:1618" name="TEMPO" comment="" chebi-id="CHEBI:32849" relevant="false">TEMPO</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.11" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.179" epochem-id="EPOCHEM:NEW:COMPOUND:812" name="4-allyloxy-TEMPO" comment="" chebi-id="WO2007045886:518160" relevant="false">4-allyloxy-TEMPO</ne>.
The steady state polymer levels for each compound are given in Table 2. Taking into account differences in molecular weight (for example, the molecular weights of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.120" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="false">4- hydroxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.12" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> are 172 and 228 respectively, giving about 25% less <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.13" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> than <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.121" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> at a fixed ppm level), the inhibitory activity of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.14" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> is comparable to the inhibitory activities of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.177" epochem-id="EPOCHEM:NEW:COMPOUND:811" name="4-methoxy-TEMPO" comment="" chebi-id="WO2007045886:176343" relevant="true">4-methoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.122" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="false">4-hydroxy-TEMPO</ne>.
</P>
<P>[0081]
EMI13.1
Table 2
Example 3
The experiment of Example 2 was repeated using combinations of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.123" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> and the other compounds.
The steady state polymer levels for each combination are given in Table 3. It is evident that the combination of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.15" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.124" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> was a more effective inhibitor than any of the other combinations. In addition, this combination was considerably more effective than the individual compounds as tested in Example 2.
</P>
<P>[0086]
EMI13.2
Table 3 Example 4
The efficacy of various inhibitors was evaluated with respect to the monomers <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.135" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.82" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.149" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.168" epochem-id="EPOCHEM:COMPOUND:3610" name="isoprene" comment="" chebi-id="CHEBI:35194" relevant="false">isoprene</ne>. The efficacy of each inhibitor was determined by heating in pure monomer or a solution of monomer in a suitable solvent(s) for a set time and at a known temperature. The storage inhibitor was removed from each monomer by distillation or treatment with neutral silica. In each of the tables below, the amount of polymer generated is expressed as % w/w of the monomer.
<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.136" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">Vinyl acetate</ne> monomer
In this case, the tubes and solution were degassed with <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.378" epochem-id="EPOCHEM:NEW:COMPOUND:749" name="Nitrogen" comment="" chebi-id="CHEBI:25555" relevant="false">nitrogen</ne> prior to sealing and heating at 16O&lt;0&gt;C for 48 hours.
As the table below illustrates, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.16" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> was found to be a more effective inhibitor than <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.35" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne>. Synergy was observed with a combination of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.374" epochem-id="EPOCHEM:NEW:COMPOUND:2058" name="4- butoxytempo" comment="4-butoxy-TEMPO" chebi-id="WO2007045886:630889" relevant="false">4- butoxytempo</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.36" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne>.
</P>
<P>[0092]
EMI14.1
<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.83" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">Acrylonitrile</ne> monomer
Similarly, tubes containing <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.84" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne> and various inhibitors were heated at 120&lt;0&gt;C for 7 days. The air was not removed from these solutions prior to heating.
As the table below illustrates, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.17" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> was found to be a more effective inhibitor than <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.125" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne>.
EMI15.1
<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.150" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-Ethylhexyl acrylate</ne> monomer
Similarly, tubes containing 5 ppm inhibitor in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.151" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne> were heated at 145&lt;0&gt;C and the results expressed as inhibition time (i.e. the time to appearance of insoluble polymer). Data were generated in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.379" epochem-id="EPOCHEM:NEW:COMPOUND:749" name="Nitrogen" comment="" chebi-id="CHEBI:25555" relevant="false">nitrogen</ne> and in the presence of air. As the table below illustrates, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.18" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> was found to be an effective inhibitor of polymerisation.
</P>
<P>[0098]
EMI15.2
<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.367" epochem-id="EPOCHEM:NEW:COMPOUND:2056" name="lsoprene" comment="isoprene" chebi-id="CHEBI:35194" relevant="false">lsoprene</ne> monomer
Similarly tubes containing 100 ppm inhibitor in a solution of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.368" epochem-id="EPOCHEM:NEW:COMPOUND:2056" name="lsoprene" comment="isoprene" chebi-id="CHEBI:35194" relevant="false">lsoprene</ne> in dimethylformamide containing 1 or 3% furfural were heated at 160 &lt;0&gt;C for 1hr. As the table below illustrates, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.19" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> was found to be an effective inhibitor of polymerisation. The results are expressed as ppm insoluble polymer.
</P>
<P>[0101]
EMI15.3
Example 5
Saturated solutions of the inhibitors/retarders <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.37" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.155" epochem-id="EPOCHEM:NEW:COMPOUND:809" name="4- methoxyphenol" comment="" chebi-id="WO2007045886:849401" relevant="false">4-methoxyphenol</ne> were prepared in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.20" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne>. These saturated solutions were then added to <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.60" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> so that the concentration of each inhibitor/retarder was above the solubility limit for that material in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.61" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> alone. The solutions were observed for physical stability at 20&lt;0&gt;C. The table below shows the soluble amount of each inhibitor/retarder in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.21" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> plus <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.62" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>:
</P>
<P>[0104]
EMI16.1
The same inhibitors were then added to <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.63" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> monomer at various concentrations in the absence of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.22" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne>, to determine if solubility was enhanced by including <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.375" epochem-id="EPOCHEM:NEW:COMPOUND:2058" name="4- butoxytempo" comment="4-butoxy-TEMPO" chebi-id="WO2007045886:630889" relevant="false">4- butoxyTEMPO</ne> in the formulation. The table below shows the solubility of the inhibitors/retarders in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.64" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne> in the absence of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.23" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne>:
</P>
<P>[0106]
EMI16.2
Comparing the two sets of experiments, it was apparent that the presence of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.24" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy- TEMPO</ne> enhanced the solubility of the other inhibitors.
Example 6
The solubility of 4-hydroxytempo in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.170" epochem-id="EPOCHEM:COMPOUND:5627" name="ethylbenzene" comment="" chebi-id="CHEBI:16101" relevant="false">ethylbenzene</ne> is only 8.1% wt/wt at 20&lt;0&gt;C. A solution of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.126" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> and <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.25" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.171" epochem-id="EPOCHEM:COMPOUND:5627" name="ethylbenzene" comment="" chebi-id="CHEBI:16101" relevant="false">ethylbenzene</ne> was prepared with a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.127" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4- hydroxy-TEMPO</ne> concentration of 14.9% with respect to <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.172" epochem-id="EPOCHEM:COMPOUND:5627" name="ethylbenzene" comment="" chebi-id="CHEBI:16101" relevant="false">ethylbenzene</ne>. This gave a clear red solution, indicating that the presence of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.26" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne> enhanced the solubility of <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.128" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne> in <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.173" epochem-id="EPOCHEM:COMPOUND:5627" name="ethylbenzene" comment="" chebi-id="CHEBI:16101" relevant="false">ethylbenzene</ne>.
</P></DIV>
<DIV><P>
CLAIMS
</P>
<P>1. A method of inhibiting polymerisation of an ethylenically unsaturated monomer, which comprises contacting the monomer with a <ne id="WO2007045886.HC.class-names.197" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> of formula (I):
EMI17.1
(I) wherein
R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.194" epochem-id="EPOCHEM:NEW:LIGAND:141" name="C4-20 hydrocarbyl" comment="" chebi-id="WO2007045886:688833" relevant="false">C4-20 hydrocarbyl</ne>; and
R [upsilon]2 , R D3 , R and R are independently each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.230" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne>.
</P>
<P>2. A method according to claim 1 , wherein the compound is of formula (N):
EMI17.2
(II)
</P>
<P>3. A method according to claim 1 or claim 2, wherein R&lt;1&gt; comprises an <ne type="LIGAND" id="WO2007045886.HC.ligand-names.277" epochem-id="EPOCHEM:NEW:LIGAND:552" name="aliphatic hydrocarbon group" comment="" chebi-id="WO2007045886:834041" relevant="false">aliphatic hydrocarbon group</ne> optionally substituted with a <ne type="LIGAND" id="WO2007045886.HC.ligand-names.280" epochem-id="EPOCHEM:NEW:LIGAND:553" name="cyclic hydrocarbon group" comment="" chebi-id="WO2007045886:555983" relevant="false">cyclic hydrocarbon group</ne>.
</P>
<P>4. A method according to claim 3, wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.200" epochem-id="EPOCHEM:NEW:LIGAND:143" name="C4-I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:283447" relevant="false">C4-I0 alkyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.233" epochem-id="EPOCHEM:NEW:LIGAND:157" name="C4--I0 alkenyl" comment="C4-10 alkenyl" chebi-id="WO2007045886:34885" relevant="false">C4--I0 alkenyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.255" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> or -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.159" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.256" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>, wherein <ne type="LIGAND" id="WO2007045886.HC.ligand-names.257" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> and -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.160" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.258" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> are optionally substituted with <ne type="LIGAND" id="WO2007045886.HC.ligand-names.161" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.151" epochem-id="EPOCHEM:NEW:LIGAND:134" name="C2-6 alkenyl" comment="" chebi-id="WO2007045886:148772" relevant="false">C2-6 alkenyl</ne>.
</P>
<P>5. A method according to claim 4, wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.235" epochem-id="EPOCHEM:NEW:LIGAND:158" name="C4--I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:833515" relevant="false">C4--I0 alkyl</ne>, in particular <ne type="LIGAND" id="WO2007045886.HC.ligand-names.112" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.77" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.205" epochem-id="EPOCHEM:NEW:LIGAND:144" name="heptyl" comment="" chebi-id="CHEBI:24526" relevant="false">heptyl</ne>.
</P>
<P>6. A method according to claim 5, wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.51" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.60" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.69" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>.
</P>
<P>7. A method according to claim 1, wherein the compound is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.2" epochem-id="EPOCHEM:NEW:COMPOUND:795" name="4-butoxy-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:862533" relevant="true">4-butoxy-2,2,6,6- tetramethylpiperidine-1 -oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.27" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne>").
</P>
<P>8. A method according to any preceding claim, which further comprises contacting the monomer with a second inhibitor of said polymerisation.
</P>
<P>9. A method according to claim 8, wherein the second inhibitor is a second <ne id="WO2007045886.HC.class-names.198" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
</P>
<P>10. A method according to claim 9, wherein the second <ne id="WO2007045886.HC.class-names.199" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is more hydrophilic than the first <ne id="WO2007045886.HC.class-names.200" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
</P>
<P>11. A method according to claim 10, wherein the second <ne id="WO2007045886.HC.class-names.201" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is a compound of formula (III):
EMI18.1
(III) wherein
R&lt;6&gt; is an atom or group which is more hydrophilic than -OR&lt;1&gt;; and
R&lt;7&gt;, R&lt;8&gt;, R&lt;9&gt; and R&lt;10&gt; are each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.162" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>.
</P>
<P>12. A method according to claim 11 , which is of formula (IV):
EMI19.1
(IV)
</P>
<P>13. A method according to claim 11 or claim 12, wherein R&lt;6&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.238" epochem-id="EPOCHEM:NEW:LIGAND:68" name="hydroxy" comment="" chebi-id="CHEBI:43176" relevant="false">hydroxy</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.242" epochem-id="EPOCHEM:NEW:LIGAND:8" name="oxo" comment="" chebi-id="CHEBI:46629" relevant="false">oxo</ne>.
</P>
<P>14. A method according to claim 9, wherein the second <ne id="WO2007045886.HC.class-names.202" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.31" epochem-id="EPOCHEM:NEW:COMPOUND:797" name="4-hydroxy- 2,2,6,6-tetramethylpiperidine-1-oxide" comment="" chebi-id="WO2007045886:624799" relevant="true">4- hydroxy-2,2,6,6-tetramethylpiperidine-1-oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.129" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne>").
</P>
<P>15. A method according to claim 9, wherein the second <ne id="WO2007045886.HC.class-names.203" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.363" epochem-id="EPOCHEM:NEW:COMPOUND:1538" name="4-oxo- 2,2,6,6-tetramethylpiperidine-i-oxide" comment="4-oxo- 2,2,6,6-tetramethylpiperidine-1-oxide" chebi-id="WO2007045886:746221" relevant="true">4-oxo- 2,2,6,6-tetramethylpiperidine-i-oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.109" epochem-id="EPOCHEM:NEW:COMPOUND:805" name="4-oxo-TEMPO" comment="" chebi-id="WO2007045886:773595" relevant="false">4-oxo-TEMPO</ne>").
</P>
<P>16. A method according to claim 9, wherein the first <ne id="WO2007045886.HC.class-names.204" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.3" epochem-id="EPOCHEM:NEW:COMPOUND:795" name="4-butoxy-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:862533" relevant="true">4-butoxy- 2,2,6,6-tetramethylpiperidine-1 -oxide</ne>, and the second <ne id="WO2007045886.HC.class-names.205" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.32" epochem-id="EPOCHEM:NEW:COMPOUND:797" name="4-hydroxy- 2,2,6,6-tetramethylpiperidine-1-oxide" comment="" chebi-id="WO2007045886:624799" relevant="true">4-hydroxy- 2,2,6,6-tetramethylpiperidine-1-oxide</ne>.
</P>
<P>17. A method according to any of claims 9 to 16, which further comprises contacting the monomer with one or more compounds selected from <ne id="WO2007045886.HC.class-names.59" epochem-id="EPOCHEM:NEW:CLASS:178" name="phenols" comment="" chebi-id="CHEBI:33853" relevant="false" type="CLASS">phenols</ne>, <ne id="WO2007045886.HC.class-names.53" epochem-id="EPOCHEM:NEW:CLASS:177" name="alkylated phenols" comment="" chebi-id="WO2007045886:532770" relevant="false" type="CLASS">alkylated phenols</ne>, <ne id="WO2007045886.HC.class-names.33" epochem-id="EPOCHEM:NEW:CLASS:173" name="nitrophenols" comment="" chebi-id="CHEBI:25562" relevant="false" type="CLASS">nitrophenols</ne>, <ne id="WO2007045886.HC.class-names.38" epochem-id="EPOCHEM:NEW:CLASS:174" name="nitrosophenols" comment="" chebi-id="WO2007045886:904246" relevant="false" type="CLASS">nitrosophenols</ne>, <ne id="WO2007045886.HC.class-names.43" epochem-id="EPOCHEM:NEW:CLASS:175" name="quinones" comment="" chebi-id="CHEBI:36141" relevant="false" type="CLASS">quinones</ne>, <ne id="WO2007045886.HC.class-names.48" epochem-id="EPOCHEM:NEW:CLASS:176" name="hydroquinones" comment="" chebi-id="CHEBI:24646" relevant="false" type="CLASS">hydroquinones</ne>, <ne id="WO2007045886.HC.class-names.12" epochem-id="EPOCHEM:NEW:CLASS:169" name="quinone ethers" comment="" chebi-id="WO2007045886:299220" relevant="false" type="CLASS">quinone ethers</ne>, <ne id="WO2007045886.HC.class-names.18" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne>, <ne id="WO2007045886.HC.class-names.23" epochem-id="EPOCHEM:NEW:CLASS:171" name="hydroxylamines" comment="" chebi-id="CHEBI:24709" relevant="false" type="CLASS">hydroxylamines</ne> and <ne id="WO2007045886.HC.class-names.28" epochem-id="EPOCHEM:NEW:CLASS:172" name="quinone methides" comment="" chebi-id="WO2007045886:173453" relevant="false" type="CLASS">quinone methides</ne>.
</P>
<P>18. A method according to any of claims 9 to 17, which further comprises contacting the monomer with a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.38" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne>, for example <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.39" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne>.
</P>
<P>19. A method according to claim 8, wherein the second inhibitor is selected from <ne id="WO2007045886.HC.class-names.61" epochem-id="EPOCHEM:NEW:CLASS:178" name="phenols" comment="" chebi-id="CHEBI:33853" relevant="false" type="CLASS">phenols</ne>, <ne id="WO2007045886.HC.class-names.54" epochem-id="EPOCHEM:NEW:CLASS:177" name="alkylated phenols" comment="" chebi-id="WO2007045886:532770" relevant="false" type="CLASS">alkylated phenols</ne>, <ne id="WO2007045886.HC.class-names.34" epochem-id="EPOCHEM:NEW:CLASS:173" name="nitrophenols" comment="" chebi-id="CHEBI:25562" relevant="false" type="CLASS">nitrophenols</ne>, <ne id="WO2007045886.HC.class-names.39" epochem-id="EPOCHEM:NEW:CLASS:174" name="nitrosophenols" comment="" chebi-id="WO2007045886:904246" relevant="false" type="CLASS">nitrosophenols</ne>, <ne id="WO2007045886.HC.class-names.44" epochem-id="EPOCHEM:NEW:CLASS:175" name="quinones" comment="" chebi-id="CHEBI:36141" relevant="false" type="CLASS">quinones</ne>, <ne id="WO2007045886.HC.class-names.49" epochem-id="EPOCHEM:NEW:CLASS:176" name="hydroquinones" comment="" chebi-id="CHEBI:24646" relevant="false" type="CLASS">hydroquinones</ne>, <ne id="WO2007045886.HC.class-names.13" epochem-id="EPOCHEM:NEW:CLASS:169" name="quinone ethers" comment="" chebi-id="WO2007045886:299220" relevant="false" type="CLASS">quinone ethers</ne>, <ne id="WO2007045886.HC.class-names.19" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne>, <ne id="WO2007045886.HC.class-names.69" epochem-id="EPOCHEM:NEW:CLASS:179" name="phenothiazines" comment="" chebi-id="CHEBI:38093" relevant="false" type="CLASS">phenothiazines</ne>, <ne id="WO2007045886.HC.class-names.24" epochem-id="EPOCHEM:NEW:CLASS:171" name="hydroxylamines" comment="" chebi-id="CHEBI:24709" relevant="false" type="CLASS">hydroxylamines</ne> and <ne id="WO2007045886.HC.class-names.29" epochem-id="EPOCHEM:NEW:CLASS:172" name="quinone methides" comment="" chebi-id="WO2007045886:173453" relevant="false" type="CLASS">quinone methides</ne>.
</P>
<P>20. A method according to any of claims 8 to 19, wherein the second inhibitor is more hydrophilic than the <ne id="WO2007045886.HC.class-names.206" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
</P>
<P>21. A method according to any preceding claim, wherein the monomer is a <ne id="WO2007045886.HC.class-names.228" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomer, for example <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.65" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.75" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]-methylstyrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.85" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.94" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.98" epochem-id="EPOCHEM:NEW:COMPOUND:801" name="divinylbenzene" comment="" chebi-id="WO2007045886:746072" relevant="false">divinylbenzene</ne> or a <ne id="WO2007045886.HC.class-names.401" epochem-id="EPOCHEM:NEW:CLASS:1100" name="diene" comment="" chebi-id="WO2007045886:811490" relevant="false" type="CLASS">diene</ne>.
</P>
<P>22. A method according to claim 21 , wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.66" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>.
</P>
<P>23. A method according to claim 21 , wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.86" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>.
</P>
<P>24. A method according to any of claims 1 to 20, wherein the monomer is an <ne id="WO2007045886.HC.class-names.88" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne>.
</P>
<P>25. A method according to claim 24, wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.143" epochem-id="EPOCHEM:COMPOUND:7898" name="butyl acrylate" comment="" chebi-id="CHEBI:3245" relevant="false">butyl acrylate</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.137" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.152" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne>.
</P>
<P>26. A composition for inhibiting polymerisation of an ethylenically unsaturated monomer, which comprises first and second inhibitors of said polymerisation, wherein the first inhibitor is a <ne id="WO2007045886.HC.class-names.207" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> and is of the formula (I):
EMI20.1
(I) wherein
R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.195" epochem-id="EPOCHEM:NEW:LIGAND:141" name="C4-20 hydrocarbyl" comment="" chebi-id="WO2007045886:688833" relevant="false">C4-20 hydrocarbyl</ne>; and
R&lt;2&gt;, R&lt;3&gt;, R&lt;4&gt; and R&lt;5&gt; are independently each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.163" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>.
</P>
<P>27. A composition according to claim 26, wherein the <ne id="WO2007045886.HC.class-names.208" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is a compound of formula (II):
EMI21.1
OD
</P>
<P>28. A composition according to claim 26 or claim 27, wherein R&lt;1&gt; comprises an <ne type="LIGAND" id="WO2007045886.HC.ligand-names.278" epochem-id="EPOCHEM:NEW:LIGAND:552" name="aliphatic hydrocarbon group" comment="" chebi-id="WO2007045886:834041" relevant="false">aliphatic hydrocarbon group</ne> optionally substituted with a <ne type="LIGAND" id="WO2007045886.HC.ligand-names.281" epochem-id="EPOCHEM:NEW:LIGAND:553" name="cyclic hydrocarbon group" comment="" chebi-id="WO2007045886:555983" relevant="false">cyclic hydrocarbon group</ne>.
</P>
<P>29. . A composition according to claim 28, wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.236" epochem-id="EPOCHEM:NEW:LIGAND:159" name="C4-10 alky!" comment="C4-10 alkyl" chebi-id="WO2007045886:157719" relevant="false">C4-10 alky!</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.18" epochem-id="EPOCHEM:NEW:LIGAND:122" name="C4-I0alkenyl" comment="C4-C10 alkenyl" chebi-id="WO2007045886:141503" relevant="false">C4-I0 alkenyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.259" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> or -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.231" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.260" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne>, wherein <ne type="LIGAND" id="WO2007045886.HC.ligand-names.261" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> and -<ne type="LIGAND" id="WO2007045886.HC.ligand-names.164" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>-<ne type="LIGAND" id="WO2007045886.HC.ligand-names.262" epochem-id="EPOCHEM:NEW:LIGAND:528" name="aryl" comment="" chebi-id="CHEBI:33338" relevant="false">aryl</ne> are optionally substituted with <ne type="LIGAND" id="WO2007045886.HC.ligand-names.232" epochem-id="EPOCHEM:NEW:LIGAND:156" name="Ci-6 alkyl" comment="C1-6-alkyl" chebi-id="WO2007045886:463239" relevant="false">Ci-6 alkyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.152" epochem-id="EPOCHEM:NEW:LIGAND:134" name="C2-6 alkenyl" comment="" chebi-id="WO2007045886:148772" relevant="false">C2-6 alkenyl</ne>.
</P>
<P>30. A composition according to claim 29, wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.201" epochem-id="EPOCHEM:NEW:LIGAND:143" name="C4-I0 alkyl" comment="C4-10 alkyl" chebi-id="WO2007045886:283447" relevant="false">C4-I0 alkyl</ne>, in particular <ne type="LIGAND" id="WO2007045886.HC.ligand-names.116" epochem-id="EPOCHEM:NEW:LIGAND:131" name="butyl" comment="" chebi-id="CHEBI:41264" relevant="false">butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.78" epochem-id="EPOCHEM:NEW:LIGAND:129" name="pentyl" comment="" chebi-id="CHEBI:25902" relevant="false">pentyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.85" epochem-id="EPOCHEM:NEW:LIGAND:130" name="hexyl" comment="" chebi-id="CHEBI:24593" relevant="false">hexyl</ne>.
</P>
<P>31. A composition according to claim 30, wherein R&lt;1&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.52" epochem-id="EPOCHEM:NEW:LIGAND:127" name="n-butyl" comment="" chebi-id="CHEBI:41264" relevant="false">n-butyl</ne>, <ne type="LIGAND" id="WO2007045886.HC.ligand-names.61" epochem-id="EPOCHEM:NEW:LIGAND:128" name="sec-butyl" comment="" chebi-id="CHEBI:45557" relevant="false">sec-butyl</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.70" epochem-id="EPOCHEM:NEW:LIGAND:20" name="tert-butyl" comment="" chebi-id="CHEBI:30355" relevant="false">tert-butyl</ne>.
</P>
<P>32. A composition according to claim 26, wherein the <ne id="WO2007045886.HC.class-names.209" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.4" epochem-id="EPOCHEM:NEW:COMPOUND:795" name="4-butoxy-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:862533" relevant="true">4- butoxy-2,2,6,6-tetramethylpiperidine-1-oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.28" epochem-id="EPOCHEM:NEW:COMPOUND:796" name="4-butoxy-TEMPO" comment="" chebi-id="WO2007045886:856368" relevant="false">4-butoxy-TEMPO</ne>").
</P>
<P>33. A composition according to any of claims 26 to 32, wherein the second inhibitor is a second <ne id="WO2007045886.HC.class-names.210" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
</P>
<P>34. A composition according to claim 33, wherein the second <ne id="WO2007045886.HC.class-names.211" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is more hydrophilic than the first <ne id="WO2007045886.HC.class-names.212" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne>.
</P>
<P>35. A composition according to claim 34, wherein the second <ne id="WO2007045886.HC.class-names.213" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is a compound of formula (III):
EMI21.2
(III) wherein
R&lt;6&gt; is an atom or group which is more hydrophilic than -OR&lt;1&gt;; and
R&lt;7&gt;, R&lt;8&gt;, R&lt;9&gt; and R&lt;10&gt; are each <ne type="LIGAND" id="WO2007045886.HC.ligand-names.165" epochem-id="EPOCHEM:NEW:LIGAND:136" name="C1-6 alkyl" comment="" chebi-id="WO2007045886:51076" relevant="false">C1-6 alkyl</ne>.
</P>
<P>36. A composition according to claim 35, wherein the second <ne id="WO2007045886.HC.class-names.214" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is of formula (IV):
EMI22.1
(IV)
</P>
<P>37. A composition according to claim 35 or claim 36, wherein R&lt;5&gt; is <ne type="LIGAND" id="WO2007045886.HC.ligand-names.239" epochem-id="EPOCHEM:NEW:LIGAND:68" name="hydroxy" comment="" chebi-id="CHEBI:43176" relevant="false">hydroxy</ne> or <ne type="LIGAND" id="WO2007045886.HC.ligand-names.243" epochem-id="EPOCHEM:NEW:LIGAND:8" name="oxo" comment="" chebi-id="CHEBI:46629" relevant="false">oxo</ne>.
</P>
<P>38. A composition according to claim 33, wherein the second <ne id="WO2007045886.HC.class-names.215" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.359" epochem-id="EPOCHEM:NEW:COMPOUND:830" name="4-hydroxy-2,2,6,6-tetramethylpiperidine-1~oxide" comment="4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxide" chebi-id="WO2007045886:985399" relevant="false">4-hydroxy-2,2,6,6-tetramethylpiperidine-1~oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.130" epochem-id="EPOCHEM:NEW:COMPOUND:806" name="4-hydroxy-TEMPO" comment="" chebi-id="WO2007045886:628084" relevant="true">4-hydroxy-TEMPO</ne>").
</P>
<P>39. A composition according to claim 33, wherein the second <ne id="WO2007045886.HC.class-names.216" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.102" epochem-id="EPOCHEM:NEW:COMPOUND:803" name="4-oxo-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:340917" relevant="true">4-oxo-2,2,6,6-tetramethylpiperidine-1-oxide</ne> ("<ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.110" epochem-id="EPOCHEM:NEW:COMPOUND:805" name="4-oxo-TEMPO" comment="" chebi-id="WO2007045886:773595" relevant="false">4-oxo-TEMPO</ne>").
</P>
<P>40. A composition according to claim 33, wherein the first <ne id="WO2007045886.HC.class-names.217" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.5" epochem-id="EPOCHEM:NEW:COMPOUND:795" name="4-butoxy-2,2,6,6- tetramethylpiperidine-1 -oxide" comment="" chebi-id="WO2007045886:862533" relevant="true">4- butoxy-2,2,6,6-tetramethylpiperidine-1-oxide</ne>, and the second <ne id="WO2007045886.HC.class-names.218" epochem-id="EPOCHEM:NEW:CLASS:1009" name="nitroxide compound" comment="" chebi-id="WO2007045886:532632" relevant="false" type="CLASS">nitroxide compound</ne> is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.33" epochem-id="EPOCHEM:NEW:COMPOUND:797" name="4-hydroxy- 2,2,6,6-tetramethylpiperidine-1-oxide" comment="" chebi-id="WO2007045886:624799" relevant="true">4- hydroxy-2,2,6,6-tetramethylpiperidine-1 -oxide</ne>.
</P>
<P>41. A composition according to any of claims 33 to 40, which further comprises one or more compounds selected from <ne id="WO2007045886.HC.class-names.63" epochem-id="EPOCHEM:NEW:CLASS:178" name="phenols" comment="" chebi-id="CHEBI:33853" relevant="false" type="CLASS">phenols</ne>, <ne id="WO2007045886.HC.class-names.55" epochem-id="EPOCHEM:NEW:CLASS:177" name="alkylated phenols" comment="" chebi-id="WO2007045886:532770" relevant="false" type="CLASS">alkylated phenols</ne>, <ne id="WO2007045886.HC.class-names.35" epochem-id="EPOCHEM:NEW:CLASS:173" name="nitrophenols" comment="" chebi-id="CHEBI:25562" relevant="false" type="CLASS">nitrophenols</ne>, <ne id="WO2007045886.HC.class-names.40" epochem-id="EPOCHEM:NEW:CLASS:174" name="nitrosophenols" comment="" chebi-id="WO2007045886:904246" relevant="false" type="CLASS">nitrosophenols</ne>, <ne id="WO2007045886.HC.class-names.45" epochem-id="EPOCHEM:NEW:CLASS:175" name="quinones" comment="" chebi-id="CHEBI:36141" relevant="false" type="CLASS">quinones</ne>, <ne id="WO2007045886.HC.class-names.50" epochem-id="EPOCHEM:NEW:CLASS:176" name="hydroquinones" comment="" chebi-id="CHEBI:24646" relevant="false" type="CLASS">hydroquinones</ne>, <ne id="WO2007045886.HC.class-names.14" epochem-id="EPOCHEM:NEW:CLASS:169" name="quinone ethers" comment="" chebi-id="WO2007045886:299220" relevant="false" type="CLASS">quinone ethers</ne>, <ne id="WO2007045886.HC.class-names.20" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne>, <ne id="WO2007045886.HC.class-names.25" epochem-id="EPOCHEM:NEW:CLASS:171" name="hydroxylamines" comment="" chebi-id="CHEBI:24709" relevant="false" type="CLASS">hydroxylamines</ne> and <ne id="WO2007045886.HC.class-names.30" epochem-id="EPOCHEM:NEW:CLASS:172" name="quinone methides" comment="" chebi-id="WO2007045886:173453" relevant="false" type="CLASS">quinone methides</ne>.
</P>
<P>42. A composition according to any of claims 33 to 41, which further comprises a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.40" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne>, for example <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.41" epochem-id="EPOCHEM:NEW:COMPOUND:798" name="phenothiazine" comment="" chebi-id="CHEBI:37932" relevant="true">phenothiazine</ne>.
</P>
<P>43. A composition according to any of claims 26 to 32, wherein the second inhibitor is selected from <ne id="WO2007045886.HC.class-names.65" epochem-id="EPOCHEM:NEW:CLASS:178" name="phenols" comment="" chebi-id="CHEBI:33853" relevant="false" type="CLASS">phenols</ne>, <ne id="WO2007045886.HC.class-names.56" epochem-id="EPOCHEM:NEW:CLASS:177" name="alkylated phenols" comment="" chebi-id="WO2007045886:532770" relevant="false" type="CLASS">alkylated phenols</ne>, <ne id="WO2007045886.HC.class-names.36" epochem-id="EPOCHEM:NEW:CLASS:173" name="nitrophenols" comment="" chebi-id="CHEBI:25562" relevant="false" type="CLASS">nitrophenols</ne>, <ne id="WO2007045886.HC.class-names.41" epochem-id="EPOCHEM:NEW:CLASS:174" name="nitrosophenols" comment="" chebi-id="WO2007045886:904246" relevant="false" type="CLASS">nitrosophenols</ne>, <ne id="WO2007045886.HC.class-names.46" epochem-id="EPOCHEM:NEW:CLASS:175" name="quinones" comment="" chebi-id="CHEBI:36141" relevant="false" type="CLASS">quinones</ne>, <ne id="WO2007045886.HC.class-names.51" epochem-id="EPOCHEM:NEW:CLASS:176" name="hydroquinones" comment="" chebi-id="CHEBI:24646" relevant="false" type="CLASS">hydroquinones</ne>, <ne id="WO2007045886.HC.class-names.15" epochem-id="EPOCHEM:NEW:CLASS:169" name="quinone ethers" comment="" chebi-id="WO2007045886:299220" relevant="false" type="CLASS">quinone ethers</ne>, <ne id="WO2007045886.HC.class-names.21" epochem-id="EPOCHEM:NEW:CLASS:170" name="amines" comment="" chebi-id="CHEBI:32952" relevant="false" type="CLASS">amines</ne>, <ne id="WO2007045886.HC.class-names.70" epochem-id="EPOCHEM:NEW:CLASS:179" name="phenothiazines" comment="" chebi-id="CHEBI:38093" relevant="false" type="CLASS">phenothiazines</ne>, <ne id="WO2007045886.HC.class-names.26" epochem-id="EPOCHEM:NEW:CLASS:171" name="hydroxylamines" comment="" chebi-id="CHEBI:24709" relevant="false" type="CLASS">hydroxylamines</ne> and <ne id="WO2007045886.HC.class-names.31" epochem-id="EPOCHEM:NEW:CLASS:172" name="quinone methides" comment="" chebi-id="WO2007045886:173453" relevant="false" type="CLASS">quinone methides</ne>.
</P>
<P>44. A composition according to any of claims 26 to 43, wherein the second inhibitor is more hydrophilic than the first inhibitor.
</P>
<P>45. A composition according to any of claims 26 to 44, which further comprises an ethylenically unsaturated monomer, for example a <ne id="WO2007045886.HC.class-names.229" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomer.
</P>
<P>46. A composition according to claim 45, wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.67" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.76" epochem-id="EPOCHEM:NEW:COMPOUND:799" name="[alpha]- methylstyrene" comment="" chebi-id="WO2007045886:484998" relevant="false">[alpha]- methylstyrene</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.100" epochem-id="EPOCHEM:NEW:COMPOUND:802" name="styrene sulphonic acid" comment="" chebi-id="WO2007045886:5313" relevant="false">styrene sulphonic acid</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.87" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.95" epochem-id="EPOCHEM:NEW:COMPOUND:800" name="vinyltoluene" comment="" chebi-id="WO2007045886:335172" relevant="false">vinyltoluene</ne>, a <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.99" epochem-id="EPOCHEM:NEW:COMPOUND:801" name="divinylbenzene" comment="" chebi-id="WO2007045886:746072" relevant="false">divinylbenzene</ne> or a <ne id="WO2007045886.HC.class-names.402" epochem-id="EPOCHEM:NEW:CLASS:1100" name="diene" comment="" chebi-id="WO2007045886:811490" relevant="false" type="CLASS">diene</ne>.
</P>
<P>47. A composition according to claim 46, wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.69" epochem-id="EPOCHEM:COMPOUND:4873" name="styrene" comment="" chebi-id="CHEBI:27452" relevant="false">styrene</ne>.
</P>
<P>48. A composition according to claim 46, wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.88" epochem-id="EPOCHEM:COMPOUND:6571" name="acrylonitrile" comment="" chebi-id="CHEBI:28217" relevant="false">acrylonitrile</ne>.
</P>
<P>49. A composition according to claim 45, wherein the monomer is an <ne id="WO2007045886.HC.class-names.89" epochem-id="EPOCHEM:NEW:CLASS:185" name="ester" comment="" chebi-id="CHEBI:35701" relevant="false" type="CLASS">ester</ne>.
</P>
<P>50. A composition according to claim 49, wherein the monomer is <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.144" epochem-id="EPOCHEM:COMPOUND:7898" name="butyl acrylate" comment="" chebi-id="CHEBI:3245" relevant="false">butyl acrylate</ne>, <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.138" epochem-id="EPOCHEM:NEW:COMPOUND:807" name="vinyl acetate" comment="" chebi-id="CHEBI:46916" relevant="false">vinyl acetate</ne> or <ne type="CHEMICAL" id="WO2007045886.HC.chemical-names.153" epochem-id="EPOCHEM:NEW:COMPOUND:808" name="2-ethylhexyl acrylate" comment="" chebi-id="WO2007045886:382124" relevant="false">2-ethylhexyl acrylate</ne>.
</P>
<P>51. Use of a compound of formula (I) as defined in claim 1, as an inhibitor of polymerisation of an ethylenically unsaturated monomer, for example a <ne id="WO2007045886.HC.class-names.230" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomer.
</P>
<P>52. Use according to claim 51 , wherein the compound is as defined in any of claims 2 to 8.
</P>
<P>53. Use of a composition as defined in any of claims 26 to 50, as an inhibitor of &lt;-&gt; polymerisation of an ethylenically unsaturated monomer, for example a <ne id="WO2007045886.HC.class-names.231" epochem-id="EPOCHEM:NEW:CLASS:1010" name="hydrocarbon" comment="" chebi-id="CHEBI:24632" relevant="false" type="CLASS">hydrocarbon</ne> monomer.
</P></DIV>
</BODY>
</PAPER>
